TACROLIMUS
Primary Myelofibrosis, Prefibrotic Stage
City of Hope Medical CenterSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Primary Myelofibrosis, Prefibrotic Stage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Azacitidine M.D. Anderson Cancer Center | Phase 1/2 | CCC |
Pevonedistat M.D. Anderson Cancer Center | Phase 1/2 | CCC |
Venetoclax M.D. Anderson Cancer Center | Phase 1/2 | CCC |
Ruxolitinib Phosphate City of Hope Medical Center | Phase 1 | CC |
Fludarabine City of Hope Medical Center | Phase 1 | CC |
Evomela City of Hope Medical Center | Phase 1 | CC |
Rapamycin City of Hope Medical Center | Phase 1 | CC |
Same molecule, other indications
TACROLIMUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →